NFE2L2 and acute kidney injury: Coincidentally, Li X. et al. (2020) then reported that in addition to activating HIF-1α, roxadustat pretreatment enhanced nuclear factor erythroid 2-related Factor 2 (Nrf2) and decreased ferroptosis at the early stage of folic acid-induced acute kidney injury and retarded fibrosis progression afterward.